Our results confirm that mucosal immune responses are elicited in the majority (96 %) of infected patients, and can persist, with 71 % of convalescent patients remaining positive for Spike specific saliva IgA for between 230 and 279 days after infection. The gene discussed is CD79A; the disease is infection.